tm logo

About 10 Trademarks found that are owned by Scynexis Inc.

Filters

88597134
Live/Registered

on 27 Apr 2021

BREXAFEMME

SCYNEXIS, Inc.

88597134 · 28 Aug 2019

27 Apr 2027

005

Pharmaceutical preparations for fungal infections; pharmaceutical prep...

78594632
Live/Registered

on 03 Feb 2018

SCYNEXIS

Scynexis, Inc.

78594632 · 24 Mar 2005

08 Feb 2027

005

House mark for a full line of pharmaceutical preparations and substanc...

78214855
Live/Registered

on 17 Nov 2017

SCYNEXIS

Scynexis, Inc.

78214855 · 14 Feb 2003

08 Nov 2027

040

042

[ Custom manufacture of chemicals and pharmaceuticals for others ],[ C...

97507451
Live/Pending

on 30 Jul 2024

SAY NO MORE

SCYNEXIS, Inc.

97507451 · 18 Jul 2022

005

044

Providing medical information regarding yeast infections and treatment...

97507445
Live/Pending

on 30 Jul 2024

BREX RX

SCYNEXIS, Inc.

97507445 · 18 Jul 2022

005

044

"RX",Providing medical information regarding yeast infections and trea...

97507457
Live/Pending

on 30 Jul 2024

BREXAFEMME

SCYNEXIS, Inc.

97507457 · 18 Jul 2022

005

Color is not claimed as a feature of the mark.,Pharmaceutical preparat...

88597137
Dead/Abandoned

on 17 Apr 2023

IBREXGYN

SCYNEXIS, Inc.

88597137 · 28 Aug 2019

005

Pharmaceutical preparations for fungal infections; pharmaceutical prep...

78594653
Dead/Cancelled

on 08 Sep 2017

SCYNEXIS

Scynexis, Inc.

78594653 · 24 Mar 2005

042

Pharmaceutical drug discovery and development services; Discovery, dev...

78594647
Dead/Cancelled

on 02 Jun 2017

SCYNEXIS

Scynexis, Inc.

78594647 · 24 Mar 2005

042

Providing databases for others featuring chemical and biological infor...

78608854
Dead/Cancelled

on 11 Nov 2016

MEDCHEM-FACTORY

Scynexis, Inc.

78608854 · 14 Apr 2005

042

MEDICINAL CHEMISTRY-FACTORY,Pharmaceutical drug discovery services; Di...

Status

All

Registered

Pending

Abandoned

Other

Categories

Class 5 (6)

Class 42 (4)

Class 44 (2)

Class 40 (1)

Attorney

Christopher m hanes (4)

Anthony j malutta (3)

Karen k won (3)

Correspondents

Anthony j malutta (3)

Gsk (3)

Karen k won (2)

Christopher m hanes (1)

Mintz levin cohn ferris glovsky and (1)

End of search results

Page 1 of 1